people don't really know about the technology behind genes etc. The firm Digene was just acquired for $1.6b in early June. It barely mentioned a rating in red herring etc. and most of the "tech" blogs. Digene works in the diagnostics area, which is going to be huge in the future. Digene specifically works in cervical cancer and its relationship to the Human papillomavirus.
Prepare to hear about a lot of diagnostics companies getting bought out in the next few years. It is the wild west of diagnostics as DNA, biomarkers and precursors become huge business.
The risk reward and potential ROI is higher than making molecules such as big pharma and the path to profitability significantly shorter and in most cases the market is larger and more consumer oriented. Big pharma may be less topical an acquirer in these spaces than Johnson and Johnson and other types of FMCG's in the next years.
Look out for someone to be building the P&G of in store/take home diagnostics, that via a mega roll-up.
The technology isn't quite there, but the regulatory shifts and advances will make it huge in 3-5 years.